Skip to content

Nycocard CRP

by Primus Corp.

510(k) K013787

Nycocard CRP is a medical device (FDA Class II; FDA product code DCK, C-Reactive Protein, Antigen, Antiserum, And Control) made by Primus Corp., cleared under FDA 510(k) K013787 on 14 May 2002, active as of 22 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK013787 Date14 May 2002ClearedStatusActive

Official records

From the FDA record

Received by the FDA
14 Nov 2001
FDA decision
14 May 2002 (Substantially Equivalent)
FDA review time
181 days from receipt to decision
Public document
510(k) statement on file with the FDA

From the FDA 510(k) record K013787 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
DCK
Device class
Class II
Regulation
21 CFR Part 866.5270
Advisory committee
Immunology
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code DCK (C-Reactive Protein, Antigen, Antiserum, And Control).

Other devices from Primus Corp.

See all devices from Primus Corp. →